he frequency of invasive fungal infections has dramatically increased in the recent years and has high mortality and morbidity. Accurate and early diagnosis is very important for the appropriate antifungal therapy. Conventional techniques like microbiology, radiological and histological remain the basis of diagnosis but have limited impact on clinical decision making. There is always a need to characterize fungi accurately and quickly, which can be done by mycology immunoassays test. The fungi are parasitic and saprophytic eukaryotic organisms. The diagnostic methods for fungal infections are direct examination, radiology, and fungal culture and non-culture methods.

This report provides a complete quantitative data and qualitative analysis on the global market for Mycology Immunoassays Testing. Market size is analysed by country, product type, application, and competitors. Expanded coverage includes additional end-user industry breakdowns and in-depth producer profiles.
Prior to COVID-19, the global market for Mycology Immunoassays Testing was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for Mycology Immunoassays Testing is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.
This report covers market size and forecasts of Mycology Immunoassays Testing, including the following market information:
Global Mycology Immunoassays Testing Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Mycology Immunoassays Testing Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Mycology Immunoassays Testing Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Mycology Immunoassays Testing Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

Key market players
Major competitors identified in this market include Roche, Abbott, Siemens, Beckman Coulter, Ortho-Clinical Diagnostics, bioMérieux, ELITechGroup, MiraVista Diagnostics, etc.

Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)

Based on the Type:
ELISA
Rapid Tests
ELISPOT
Polymerase Chain Reaction (PCR)

Based on the Application:
Hospitals
Blood Banks
Others